News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Oramed Pharmaceuticals Inc. (ORMP.OB) Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013 .


4/18/2013 6:43:40 AM

JERUSALEM, April 18, 2013 /PRNewswire/ --

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced today that its abstract, titled "Oral insulin may be effective in lowering hepatic insulin resistance and inflammation in patients with type 2 diabetes," has been selected for poster presentation at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria.


Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES